Abstract

Lennox-Gastaut syndrome is commonly characterized by a triad of features including multiple seizure types, intellectual disability or regression. The long-term prognosis for Lennox-Gastaut syndrome is generally poor due to uncontrolled seizures. Lennox-Gastaut syndrome type of seizures is epilepsy which is due to abnormal vibrations occurring in seizures. During the time of such abnormal vibrations, both the seizures and the lungs suffer a lack in oxygen content to a considerable extent. This results in prolonged vibrations and loses of nervous control. As a neuro-lung protective strategy, a novel attempt has been made to enrich both seizures and lungs with oxygen content through the support of perfluorodecalin (an excellent oxygen carrier) C10F18 along with an enhancement in the antiepileptic activity by the two chosen antiepileptic drugs carbamazepine and benzodiazepine. The ultraviolet-visible spectrophotometer, fluorescence spectrograph, ultrasonic laser diffraction and scanning electron microscope studies reveals the co-existence of fluorine and drug in the emulsion produced by the sonication of both perfluorodecalin and the drug together. The presence of adequate fluorine and carbon play a catalytic role in ensuring the oxygen content and the antiepileptic activity of drug components.